Pharmacovigilance Risk-benefit optimisation … November 2010 Pharmacovigilance Regulatory Science...

2
www.pharminvent.com November 2010 Pharmacovigilance Regulatory Science Risk Management Risk-benefit optimisation Advanced Therapies Biologics Biosimilars Generics Small molecules Centrally authorised Decentralised procedures Mutually recognised Nationally authorised

Transcript of Pharmacovigilance Risk-benefit optimisation … November 2010 Pharmacovigilance Regulatory Science...

Page 1: Pharmacovigilance Risk-benefit optimisation … November 2010 Pharmacovigilance Regulatory Science Risk Management Risk-benefit optimisation Advanced Therapies Biologics ... November

www.pharminvent.com November2010

Pharmacovigilance

Regulatory Science

Risk Management

Risk-benefit optimisation

Advanced Therapies

Biologics

Biosimilars

Generics

Small molecules

Centrally authorised

Decentralised procedures

Mutually recognised

Nationally authorised

Page 2: Pharmacovigilance Risk-benefit optimisation … November 2010 Pharmacovigilance Regulatory Science Risk Management Risk-benefit optimisation Advanced Therapies Biologics ... November

www.pharminvent.com November2010

PharmInvent is led by experienced

EU ex-regulators, including former

members of CHMP and PhVWP, EMA

managers, as well as ICH and CIOMS

expert group members.


Pharmacovigilance Risk Assessment Committee(PRAC )€¦ · 11 January 2016 . EMA/PRAC/22240/2016 . Procedure Management and Committees Support Division . Pharmacovigilance Risk Assessment

Pharmacovigilance Risk Assessment Committee(PRAC )€¦ · 11 January 2016 . EMA/PRAC/22240/2016 . Procedure Management and Committees Support Division . Pharmacovigilance Risk Assessment

Risk Management: An Industry Perspective · 2019-05-16 · Risk Management. ICH E2E Pharmacovigilance Planning - The “ E2E: Pharmacovigilance Planning ” guideline is intended

Risk Management: An Industry Perspective · 2019-05-16 · Risk Management. ICH E2E Pharmacovigilance Planning - The “ E2E: Pharmacovigilance Planning ” guideline is intended

9 October 2014 EMA/686022/2014 Pharmacovigilance Risk ... · 9 October 2014 . EMA/686022/2014 . Pharmacovigilance Risk Assessment Committee (PRAC) Assessment report . Procedure under

9 October 2014 EMA/686022/2014 Pharmacovigilance Risk ... · 9 October 2014 . EMA/686022/2014 . Pharmacovigilance Risk Assessment Committee (PRAC) Assessment report . Procedure under

Pharmacovigilance and Risk Management Strategies Conference · Pharmacovigilance and Risk Management Strategies Conference Short Courses: January 19-22, 25 | Conference: January 26-28

Pharmacovigilance and Risk Management Strategies Conference · Pharmacovigilance and Risk Management Strategies Conference Short Courses: January 19-22, 25 | Conference: January 26-28

Risk optimisation

Risk optimisation

Pharmacovigilance Risk Assessment Committee (PRAC) · 5 May 2017 . EMA/PRAC/271304/2017 Inspections, Human Medicines Pharmacovigilance and Committees Division . Pharmacovigilance

Pharmacovigilance Risk Assessment Committee (PRAC) · 5 May 2017 . EMA/PRAC/271304/2017 Inspections, Human Medicines Pharmacovigilance and Committees Division . Pharmacovigilance

Pharmacovigilance Risk Assessment Committee (PRAC) · 3 April 2017 EMA/PRAC/227083/2017 Inspections, Human Medicines Pharmacovigilance and Committees Division Pharmacovigilance Risk

Pharmacovigilance Risk Assessment Committee (PRAC) · 3 April 2017 EMA/PRAC/227083/2017 Inspections, Human Medicines Pharmacovigilance and Committees Division Pharmacovigilance Risk

Pharmacovigilance Risk Assessment Committee (PRAC) · Pharmacovigilance Risk Assessment Committee (PRAC)

Pharmacovigilance Risk Assessment Committee (PRAC) · Pharmacovigilance Risk Assessment Committee (PRAC)

Pharmacovigilance Risk Assessment Committee (PRAC) · 8 May 2014 . EMA/315293/2014 . Pharmacovigilance Risk Assessment Committee (PRAC) Pharmacovigilance Risk Assessment Committee

Pharmacovigilance Risk Assessment Committee (PRAC) · 8 May 2014 . EMA/315293/2014 . Pharmacovigilance Risk Assessment Committee (PRAC) Pharmacovigilance Risk Assessment Committee

Presentation: Pharmacovigilance - a regulator's perspective · – Summary of Safety Concerns – Pharmacovigilance Plan – Risk Minimisation Plan – Australian-specific Annex.

Presentation: Pharmacovigilance - a regulator's perspective · – Summary of Safety Concerns – Pharmacovigilance Plan – Risk Minimisation Plan – Australian-specific Annex.

Pharmacovigilance Risk Assessment Committee (PRAC) · 7 April 2015 . EMA/PRAC/59170/2015 . Procedure Management & Business Support Division . Pharmacovigilance Risk Assessment Committee

Pharmacovigilance Risk Assessment Committee (PRAC) · 7 April 2015 . EMA/PRAC/59170/2015 . Procedure Management & Business Support Division . Pharmacovigilance Risk Assessment Committee

Benefit-risk evaluation and Pharmacovigilance Planning ...

Benefit-risk evaluation and Pharmacovigilance Planning ...

Pharmacovigilance Risk Assessment Committee (PRAC) · 7 May 2015 . EMA/PRAC/332948/2015 . Procedure Management and Committees Support Division . Pharmacovigilance Risk Assessment

Pharmacovigilance Risk Assessment Committee (PRAC) · 7 May 2015 . EMA/PRAC/332948/2015 . Procedure Management and Committees Support Division . Pharmacovigilance Risk Assessment

Pharmacovigilance Risk Assessment Committee (PRAC)...EMA/PRAC/459031/2020 Human Medicines Division Pharmacovigilance Risk Assessment Committee (PRAC) Draft agenda for the meeting on

Pharmacovigilance Risk Assessment Committee (PRAC)...EMA/PRAC/459031/2020 Human Medicines Division Pharmacovigilance Risk Assessment Committee (PRAC) Draft agenda for the meeting on

Pharmacovigilance Risk Assessment Committee (PRAC) · 7 March 2013 . EMA/162000/2013 . Pharmacovigilance Risk Assessment Committee (PRAC) Pharmacovigilance Risk Assessment Committee

Pharmacovigilance Risk Assessment Committee (PRAC) · 7 March 2013 . EMA/162000/2013 . Pharmacovigilance Risk Assessment Committee (PRAC) Pharmacovigilance Risk Assessment Committee

PHARMACOVIGILANCE FOR PRACTICAL BEGINNERS · the field of pharmacovigilance and risk management. Pharmacovigilance WHO defines Pharmacovigilance as “the science and activities relating

PHARMACOVIGILANCE FOR PRACTICAL BEGINNERS · the field of pharmacovigilance and risk management. Pharmacovigilance WHO defines Pharmacovigilance as “the science and activities relating

ENCePP Plenary: New Pharmacovigilance legislation · An agency of the European Union Peter Arlett. Head of Pharmacovigilance and Risk Management. EMA. ENCePP Plenary: New Pharmacovigilance

ENCePP Plenary: New Pharmacovigilance legislation · An agency of the European Union Peter Arlett. Head of Pharmacovigilance and Risk Management. EMA. ENCePP Plenary: New Pharmacovigilance

Pharmacovigilance Risk Management Signal Detection … · safety/pharmacovigilance, risk management, signal detection, and assessment – as a . ... (Eudravigilance, FDA) • xEVMPD

Pharmacovigilance Risk Management Signal Detection … · safety/pharmacovigilance, risk management, signal detection, and assessment – as a . ... (Eudravigilance, FDA) • xEVMPD

Pharmacovigilance Risk Assessment Committee (PRAC) · 08 July 2013 . EMA/PRAC/417172/2013 . Pharmacovigilance Risk Assessment Committ ee (PRAC) Pharmacovigilance Risk Assessment Committee

Pharmacovigilance Risk Assessment Committee (PRAC) · 08 July 2013 . EMA/PRAC/417172/2013 . Pharmacovigilance Risk Assessment Committ ee (PRAC) Pharmacovigilance Risk Assessment Committee

Three years of the Pharmacovigilance Risk Assessment ... · Three years of the Pharmacovigilance Risk Assessment Committee – Where ... that “the Pharmacovigilance Risk Assessment

Three years of the Pharmacovigilance Risk Assessment ... · Three years of the Pharmacovigilance Risk Assessment Committee – Where ... that “the Pharmacovigilance Risk Assessment